The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Ehealth Inc

Nasdaq: EHTH
Last

(U.S.) $27.11

Today's change-0.36 -1.31%
Updated December 22 10:22 AM EST. Delayed by at least 15 minutes.
 

Ehealth Inc

Nasdaq: EHTH
Last

(U.S.) $27.11

Today's change-0.36 -1.31%
Updated December 22 10:22 AM EST. Delayed by at least 15 minutes.

Ehealth Inc down (U.S.)$0.36

Ehealth Inc is lower today, dropping (U.S.)$0.36 or 1.31% to (U.S.)$27.11. Over the last five days, shares have gained 4.15%, but are down 41.69% for the last year to date. Shares have underperformed the S&P 500 by 51.46% during the last year.

Key company metrics

  • Open(U.S.) $27.46
  • Previous close(U.S.) $27.47
  • High(U.S.) $27.46
  • Low(U.S.) $26.92
  • Bid / Ask(U.S.) $27.07 / (U.S.) $27.15
  • YTD % change-41.69%
  • Volume14,814
  • Average volume (10-day)263,448
  • Average volume (1-month)204,102
  • Average volume (3-month)207,370
  • 52-week range(U.S.) $18.70 to (U.S.) $63.32
  • Beta0.90
  • Trailing P/E560.82×
  • P/E 1 year forward565.23×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $0.05
Updated December 22 10:22 AM EST. Delayed by at least 15 minutes.
S&P TSX0.15%Sector:FinancialsIndustry:Insurance - Life & Health
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue41435154
Total other revenue--------
Total revenue41435154
Gross profit40424953
Total cost of revenue1121
Total operating expense37365457
Selling / general / administrative36355255
Research & development--------
Depreciation / amortization0000
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income46-3-3
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax46-3-3
Income after tax23-2-2
Income tax, total23-2-1
Net income23-2-2
Total adjustments to net income--------
Net income before extra. items23-2-2
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items23-2-2
Inc. avail. to common incl. extra. items23-2-2
Diluted net income23-2-2
Dilution adjustment----00
Diluted weighted average shares18201919
Diluted EPS excluding extraordinary itemsvalue per share0.080.15-0.08-0.10
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share0.080.15-0.08-0.10